Everyday activities can be more challenging for a child with Attention Deficit Hyperactivity Disorder (ADHD).

CONCERTA® (methylphenidate hydrochloride) can help your child focus at home and at school.

DRUG DEPENDENCE: CONCERTA® should be given cautiously to patients with a history of drug dependence or alcoholism.  Chronic abusive use can lead to marked tolerance and psychological dependence with varying degrees of abnormal behaviour.  Frank psychotic episodes can occur, especially with parenteral abuse.  Careful supervision is required during withdrawal from abusive use since severe depression may occur.  Withdrawal following chronic therapeutic use may unmask symptoms of the underlying disorder that may require follow-up.

1. CONCERTA Production Information

Indications

CONCERTA® For the treatment of Attention Deficit Hyperactivity Disorder (ADHD).

PBS information

Treatment of attention deficit hyperactivity disorder (ADHD) in a patient diagnosed between the ages of 6 and 18 years inclusive, who has demonstrated a response to immediate release methylphenidate hydrochloride with no emergence of serious adverse events, and who requires continuous coverage over 12 hours

S8 – Controlled Drug

Please consult the PBS schedule for full information, available at www.pbs.gov.au

Dosage and Administration

CONCERTA® is administered orally once daily and should be taken in the morning. CONCERTA® must be swallowed whole with the aid of liquids, and must not be chewed, divided or crushed. CONCERTA® may be administered with or without food. Treatment should be started on the lowest possible dose.  

For further information please consult Dosage and Administration in Product Information

Safety Information

Please review Product Information before prescribing